๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

P-285 Clinical significance of platelet associated immunoglobulin G in interferon therapy for chronic hepatitis C

โœ Scribed by Yoshiaki Hashimoto; Toshiyuki Otsuka; Hiroaki Nakajima; Kenji Katagai; Emiko Kaneko; Ken Takehara; Toshihiko Yamada; Takayuki Arai; Hitoshi Takagi; Jiro Takezawa; Takeaki Nagamine; Shoji Yamada; Masatomo Mori


Book ID
113402173
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
127 KB
Volume
3
Category
Article
ISSN
0928-4346

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Analysis of clinical and virological fac
โœ Dr. J. A. Garson; K. Whitby; R. Deaville; S. Brillanti; M. Foli; C. Masci; M. Mi ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 508 KB

## Abstract Interferon alpha (IFNโ€ฮฑ) therapy is currently the treatment of choice for chronic hepatitis C (HCV) infection, but it fails to achieve a sustained response in approximately 75% of those treated. The factors which determine whether or not an individual will respond to IFNโ€ฮฑ are uncertain

Clinical significance of hepatic HCV RNA
โœ Larghi, Alberto; Tagger, Alessandro; Crosignani, Andrea; Ribero, Maria Lisa; Bru ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB ๐Ÿ‘ 2 views

Whether sustained biochemical response and absence of serum HCV RNA in the 6-12 months following suspension of interferon-โฃ (IFN-โฃ) therapy reflect definitive viral clearance in patients with chronic hepatitis C virus (HCV) infection is controversial. To obtain more information on this topic, HCV RN